Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: December 15, 2025
Reporting Period: Event date December 15, 2025; Reverse stock split effective December 15, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and listing status events.
Material Changes
- Nasdaq Deficiency Notice: Received a deficiency letter from Nasdaq on December 15, 2025, due to the closing bid price remaining below $1.00 per share for 30 consecutive business days, violating Listing Rule 5550(a)(2).
- Reverse Stock Split: To address the deficiency, the Company filed a Certificate of Amendment for a 1-for-10 reverse stock split. This became effective at 11:59 p.m. Eastern Time on December 15, 2025, with trading on a split-adjusted basis commencing December 16, 2025.
Guidance, Outlook, and Risks
- Compliance Period: The Company has an initial 180-day compliance period (until June 15, 2026) to regain compliance. Compliance is achieved if the closing bid price is at least $1.00 for 10 consecutive business days.
- Delisting Risk: Failure to regain compliance by June 15, 2026, may result in delisting. While an additional 180-day period may be available if other listing standards are met, there is no assurance of eligibility.
- Appeal Rights: If delisting is imminent, the Company retains the right to appeal to a Nasdaq Hearings Panel.
Investor Verification Checklist
- Verify the post-split trading price of INBS on December 16, 2025, to assess immediate impact of the 1-for-10 reverse split.
- Monitor the stock price over the next 10 consecutive business days to determine if the $1.00 threshold is met.
- Review the Company's capital structure and market value of publicly held shares to assess eligibility for a potential second 180-day compliance period.
- Confirm the exact number of shares outstanding post-split to evaluate dilution or concentration effects.